Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 1, 2015, Pages 98-103

  Divekar, Rohit ^a   Kita, Hirohito ^a  

^a MAYO CLINIC   (United States)

Author keywords

Airway remodeling; allergic inflammation; asthma; atopic dermatitis; IL 25; IL 33; thymic stromal lymphopoietin

Indexed keywords

INTERLEUKIN 25; INTERLEUKIN 33; THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE; IL25 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN DERIVATIVE;

AIRWAY REMODELING; ALLERGIC DISEASE; ASTHMA; ATOPIC DERMATITIS; CYTOKINE RELEASE; ENVIRONMENTAL FACTOR; EPITHELIUM; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; LYMPHOID CELL; MAST CELL; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; RESPIRATORY TRACT MUCOSA;

ANIMALS; CYTOKINES; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-33; INTERLEUKINS; RESPIRATORY MUCOSA;

EID: 84920876065     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000133     Document Type: Review

References (42)

1. Bartemes KR, Hirohito Kita. Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol 2012; 143:222-235.
2. Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev 2011; 242:10-30.
3. Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol 2010; 126:976-984; 984.e1-984.e5.
4. Bogiatzi SI, Fernandez I, Bichet JC, et al. Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol 2007; 178:3373-3377.
5. Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009; 183:1427-1434.
6. Bleck B, Grunig G, Chiu A, et al. MicroRNA-375 regulation of thymic stromal lymphopoietin by diesel exhaust particles and ambient particulate matter in human bronchial epithelial cells. J Immunol 2013; 190:3757-3763.
7. Schuepbach-Mallepell S, Philippe V, Brüggen MC, et al. Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin. J Allergy Clin Immunol 2013; 132:1348-1357.
8. Hackett TL, de Bruin HG, Shaheen F, et al. Caveolin-1 controls airway epithelial barrier function. Implications for asthma. Am J Respir Cell Mol Biol 2013; 49:662-671.
9. Yeh CY, Yeh TH, Jung CJ, et al. Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens. PLoS One 2013; 8:e55472.
10. Siracusa MC, Saenz SA, Wojno ED, et al. Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation. Immunity 2013; 39:1158-1170.
11. Yao W, Zhang Y, Jabeen R, et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013; 38:360-372.
12. Cheng DT, Ma C, Niewoehner J, et al. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol 2013; 32:455-462.
13. Gauvreau GM, O'Byrne PM, Boulet LP, et al. Effectsofananti-TSLPantibodyon allergen-induced asthmatic responses. N Engl J Med 2014; 370:2102-2110.
14. Du MR, Guo PF, Piao HL, et al. Embryonic trophoblasts induce decidual regulatory T cell differentiation and maternal-fetal tolerance through thymic stromal lymphopoietin instructing dendritic cells. J Immunol 2014; 192:1502-1511.
15. Lee HC, Sung SS, Krueger PD, et al. Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes. Hepatology 2013; 57:1314-1324.
16. Wilson SR, Thé L, Batia LM, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 2013; 155:285-295.
17. Kim BS, Siracusa MC, Saenz SA, et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013; 5:No. 170, 170ra16.
18. Nagarkar DR, Poposki JA, Tan BK, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol 2013; 132:593-600.
19. Datta A, Alexander R, Sulikowski MG, et al. Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease. J Immunol 2013; 191:4867-4879.
20. Kwon BI, Hong S, Shin K, et al. Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax. Am J Respir Crit Care Med 2013; 188:577-585.
21. Kouzaki H, Tojima I, Kita H, Shimizu T. Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells. Am J Respir Cell Mol Biol 2013; 49:741-750.
22. Salimi M, Barlow JL, Saunders SP. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013; 210:2939-2950.
23. Kim BE, Bin L, Ye YM, et al. IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol 2013; 133:2678-2685.
24. Hams E, Armstrong ME, Barlow JL, et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci USA 2014; 111:367-372.
25. Gregory LG, Jones CP, Walker SA, et al. IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax 2013; 68:82-90.
26. Barlow JL, Peel S, Fox J, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013; 132:933-941.
27. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367-1370.
28. Tang W, Smith SG, Beaudin S, et al. IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma. Int Arch Allergy Immunol 2014; 163:5-10.
29. Lam M, Hull L, McLachlan R, et al. Clinical severity and epithelial endotypes in chronic rhinosinusitis. Int Forum Allergy Rhinol 2013; 3:121-128.
30. Su J, Chen T, Ji XY, et al. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease. Inflamm Bowel Dis 2013; 19:720-728.
31. Ho JE, Chen WY, Chen MH, et al. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. J Clin Invest 2013; 123:4208-4218.
32. Martínez-González I, Roca O, Masclans JR, et al. Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 2013; 49:552-562.
33. Roy A, Ganesh G, Sippola H, et al. Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J Biol Chem 2014; 289:237-250.
34. Chu DK, Llop-Guevara A, Walker TD, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 2013; 131:187-200.
35. Luzina IG, Kopach P, Lockatell V, et al. Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol 2013; 49:999-1008.
36. Jung MY, Smrz D, Desai A, et al. IL-33 induces a hyporesponsive phenotype in human and mouse mast cells. J Immunol 2013; 190:531-538.
37. Roussel L, Farias R, Rousseau S. IL-33 is expressed in epithelia from patients with cystic fibrosis and potentiates neutrophil recruitment. J Allergy Clin Immunol 2013; 131:913-916.
38. Enoksson M, Möller-Westerberg C, Wicher G, et al. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent. Blood 2013; 121:530-536.
39. Fock V, Mairhofer M, Otti GR, et al. Macrophage-derived IL-33 is a critical factor for placental growth. J Immunol 2013; 191:3734-3743.
40. Hamzaoui A, Berraies A, Kaabachi W, et al. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. J Asthma 2013; 50:803-809.
41. Byers DE, Alexander-Brett J, Patel AC, et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 2013; 123:3967-3982.
42. Shaw JL, Fakhri S, Citardi MJ, et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 inchronic rhinosinusitis with nasal polyps. Am JRespir Crit Care Med 2013; 188:432-439.